Julphar Partners With AIM Congress 2025 To Enhance Global Manufacturing And Investment Initiatives

The AIM Congress has confirmed a partnership with Gulf Pharmaceutical Industries, known as Julphar, as the "Lead Partner" for its Global Manufacturing Portfolio. This collaboration is supported by the Emirates Drug Establishment (EDE) at the 14th Edition of AIM Congress 2025 in Abu Dhabi. The event serves as a key platform for promoting collaboration and economic development through investment, involving over 400 partners worldwide.

Basel Ziyadeh, CEO of Julphar, shared his excitement about this partnership. He stated, "For over four decades, Julphar has been at the forefront of the pharmaceutical industry, setting benchmarks for excellence and innovation while playing a vital role in shaping the UAE’s pharmaceutical landscape."

This strategic alliance between AIM Congress and Julphar highlights their mutual dedication to enhancing collaborative efforts. It aims to foster knowledge sharing and accelerate sustainable growth and digital transformation within the manufacturing sector. This initiative aligns with the UAE's vision to become a global hub for trade, manufacturing, and healthcare innovations.

Dawood Al-Shezawi, President of AIM Global Foundation and Chairman of the AIM Congress Organising Committee, stressed the significance of this partnership. He noted that working with a leading company like Julphar boosts efforts to develop the industrial sector. It supports the summit’s goal of creating a sustainable investment ecosystem that aids global economic progress.

The Global Manufacturing portfolio will spotlight the pharmaceutical industry as an innovation leader. It will leverage smart manufacturing, data analytics, and automation to improve quality, efficiency, and sustainability. By adopting advanced technologies from Industry 5.0, pharmaceutical manufacturers aim to boost productivity and reduce waste.

Ziyadeh further added, "We are honoured to collaborate with the Emirates Drug Establishment (EDE) and AIM Congress to drive impactful developmental strategies. This partnership promotes teamwork and cultivates partnerships that enhance equitable access to high-quality healthcare solutions."

Exploring Technological Advancements

The theme for Global Manufacturing at AIM Congress 2025 is "From Industry 4.0 to 5.0: Leveraging Technology & Advancing Smart Factories." Discussions will focus on transforming manufacturing ecosystems through product innovation and operational efficiency while ensuring sustainability.

Key areas include minimising manual processes, optimising resource use, ensuring worker safety, and boosting productivity and competitiveness. The portfolio will also explore how advanced technologies help companies tackle future challenges in an evolving global environment.

Impact on Economic Development

The partnership between AIM Congress and Julphar underscores their commitment to strengthening collaborative initiatives. It aims to foster knowledge exchange while accelerating sustainable growth in manufacturing. This collaboration supports foreign direct investment (FDI) in line with reinforcing UAE’s leadership in pharmaceuticals.

Al-Shezawi highlighted the crucial role of pharmaceutical manufacturing in supporting national economies by providing innovative solutions that enhance quality of life. He remarked that this partnership is a strategic move towards advancing pharmaceuticals while attracting more investments into this essential sector.

This collaboration significantly contributes to strengthening global health security at regional and national levels by promoting equitable access to healthcare solutions. It also enhances efforts towards building a sustainable investment ecosystem contributing positively towards economic development globally.

With inputs from WAM